Pharis Mohideen - 29 Jul 2022 Form 4 Insider Report for DBV Technologies S.A. (DBVT)

Role: Chief Medical Officer
Signature: /s/ Jason Minio, Attorney-in-Fact
Issuer symbol: DBVT
Transactions as of: 29 Jul 2022
Net transactions value: -$6,821
Form type: 4
Filing time: 14 Aug 2023, 16:32:21 UTC
Previous filing: 24 Nov 2021
Next filing: 22 Nov 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DBVT	Ordinary Shares	Award	$0	+10,000	+41%	$0.000000	34,200	29 Jul 2022	Direct	F1, F2
transaction	DBVT	Ordinary Shares	Award	$0	+17,500	+51%	$0.000000	51,700	21 Nov 2022	Direct	F1, F3
transaction	DBVT	Ordinary Shares	Sale	$5,161	-1,792	-3.5%	$2.88	49,908	24 Nov 2022	Direct	F1, F4, F5
transaction	DBVT	Ordinary Shares	Sale	$1,660	-469	-0.94%	$3.54	49,439	24 May 2023	Direct	F1, F4, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DBVT	Employee Stock Option (right to buy)	Award	$0	+100,000		$0.000000	100,000	29 Jul 2022	Ordinary Shares	100,000	$4.83	Direct	F7, F8
transaction	DBVT	Employee Stock Option (right to buy)	Award	$0	+115,000		$0.000000	115,000	21 Nov 2022	Ordinary Shares	115,000	$3.07	Direct	F9, F10

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The ordinary shares may be represented by American Depositary Shares, each of which currently represents one-half of one ordinary share.
F2	Represents the Issuer's ordinary shares underlying a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one ordinary share. 25% of the shares underlying the RSU vest on July 29, 2023, with the remaining shares vesting in six equal semi-annual installments thereafter, subject in each case to the Reporting Person continuing to provide service through each such date.
F3	Represents the Issuer's ordinary shares underlying a restricted stock unit RSU award. Each RSU represents a contingent right to receive one ordinary share. 25% of the shares underlying the RSU vest on November 21, 2023, with the remaining shares vesting in six equal semi-annual installments thereafter, subject in each case to the Reporting Person continuing to provide service through each such date.
F4	Shares sold to satisfy withholding tax obligations upon the the vesting of RSUs.
F5	This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.0409 to EURO 1.00 as of November 24, 2022.
F6	This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.0746 to EURO 1.00 as of May 24, 2023.
F7	This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.0226 to EURO 1.00 as of July 29, 2022.
F8	25% of the shares subject to the option vest on July 29, 2023, with the remaining shares vesting in six equal semi-annual installments thereafter, subject to the Reporting Person continuing to provide service through each such date.
F9	This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.0242 to EURO 1.00 as of November 21, 2022.
F10	25% of the shares subject to the option vest on November 21, 2023, with the remaining shares vesting in six equal semi-annual installments thereafter, subject to the Reporting Person continuing to provide service through each such date.